220 related articles for article (PubMed ID: 15846369)
1. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.
Hendriks J; Planelles L; de Jong-Odding J; Hardenberg G; Pals ST; Hahne M; Spaargaren M; Medema JP
Cell Death Differ; 2005 Jun; 12(6):637-48. PubMed ID: 15846369
[TBL] [Abstract][Full Text] [Related]
2. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
4. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
Kimberley FC; van Bostelen L; Cameron K; Hardenberg G; Marquart JA; Hahne M; Medema JP
FASEB J; 2009 May; 23(5):1584-95. PubMed ID: 19141538
[TBL] [Abstract][Full Text] [Related]
5. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
6. The crystal structure of a proliferation-inducing ligand, APRIL.
Wallweber HJ; Compaan DM; Starovasnik MA; Hymowitz SG
J Mol Biol; 2004 Oct; 343(2):283-90. PubMed ID: 15451660
[TBL] [Abstract][Full Text] [Related]
7. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.
Deshayes F; Laprée G; Portier A; Richard Y; Pencalet P; Mahieu-Caputo D; Horellou P; Tsapis A
Oncogene; 2004 Apr; 23(17):3005-12. PubMed ID: 14691452
[TBL] [Abstract][Full Text] [Related]
8. Expression and purification of APRIL by auto-induction.
Yu S; Wang Y; Liu Y; Mo W; Song H; Yu M
Protein Expr Purif; 2009 Nov; 68(1):49-53. PubMed ID: 19545632
[TBL] [Abstract][Full Text] [Related]
9. "APRIL hath put a spring of youth in everything": Relevance of APRIL for survival.
Kimberley FC; Hahne M; Medema JP
J Cell Physiol; 2009 Jan; 218(1):1-8. PubMed ID: 18726990
[TBL] [Abstract][Full Text] [Related]
10. Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage display.
Gordon NC; Lien S; Johnson J; Wallweber HJ; Tran T; Currell B; Mathieu M; Quan C; Starovasnik MA; Hymowitz SG; Kelley RF
J Mol Biol; 2010 Feb; 396(1):166-77. PubMed ID: 19945466
[TBL] [Abstract][Full Text] [Related]
11. The source of APRIL up-regulation in human solid tumor lesions.
Mhawech-Fauceglia P; Kaya G; Sauter G; McKee T; Donze O; Schwaller J; Huard B
J Leukoc Biol; 2006 Oct; 80(4):697-704. PubMed ID: 16793914
[TBL] [Abstract][Full Text] [Related]
12. The uncertain glory of APRIL.
Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes.
Karpusas M; Cachero TG; Qian F; Boriack-Sjodin A; Mullen C; Strauch K; Hsu YM; Kalled SL
J Mol Biol; 2002 Feb; 315(5):1145-54. PubMed ID: 11827482
[TBL] [Abstract][Full Text] [Related]
14. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
15. Ligand-receptor binding revealed by the TNF family member TALL-1.
Liu Y; Hong X; Kappler J; Jiang L; Zhang R; Xu L; Pan CH; Martin WE; Murphy RC; Shu HB; Dai S; Zhang G
Nature; 2003 May; 423(6935):49-56. PubMed ID: 12721620
[TBL] [Abstract][Full Text] [Related]
16. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
[TBL] [Abstract][Full Text] [Related]
17. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
18. The role of APRIL and BAFF in lymphocyte activation.
Schneider P
Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
[TBL] [Abstract][Full Text] [Related]
19. CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.
Kurzeder C; Koppold B; Sauer G; Pabst S; Kreienberg R; Deissler H
Int J Mol Med; 2007 Feb; 19(2):325-33. PubMed ID: 17203208
[TBL] [Abstract][Full Text] [Related]
20. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
Forsten-Williams K; Chua CC; Nugent MA
J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
